Dose Adaptation of Capecitabine Using Mobile Phone Toxicity Monitoring (DATACAP)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01053104
Recruitment Status : Completed
First Posted : January 21, 2010
Last Update Posted : July 25, 2012
Vodafone UK Foundation
Centre of Statistics and Medicine (CSM, Oxford)
Oncology Clinical Trials Office (OCTO, Oxford)
Information provided by (Responsible Party):
University of Oxford

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : December 2010
  Actual Study Completion Date : April 2011